AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways.

AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways. — المؤلف: Chow, Raymond Kwok Kei — Oncotarget Oct 2017

المؤلف
Chow, Raymond Kwok Kei
النشر
Oncotarget Oct 2017
الوصف
83469-83479 p.